Is sleeve gastrectomy as effective as gastric bypass for remission of type 2 diabetes in morbidly obese patients?

2011 ◽  
Vol 7 (4) ◽  
pp. 506-509 ◽  
Author(s):  
Amador García Ruiz de Gordejuela ◽  
Jordi Pujol Gebelli ◽  
Núria Vilarrasa García ◽  
Enric Fernández Alsina ◽  
Lluis Secanella Medayo ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Gastric Bypass ◽  
Sleeve Gastrectomy ◽  
Morbidly Obese ◽  
Obese Patients

Diverted sleeve gastrectomy with ileal transposition in overweight, obese, and morbidly obese patients with type 2 diabetes: results of 1-year follow-up

2016 ◽  
Vol 12 (3) ◽  
pp. 541-549 ◽  
Author(s):  
Alper Celik ◽  
Eylem Cagiltay ◽  
Surendra Ugale ◽  
Muharrem Asci ◽  
Bahri Onur Celik ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Sleeve Gastrectomy ◽  
Morbidly Obese ◽  
Obese Patients ◽  
Ileal Transposition

Long-term remission of type 2 diabetes in morbidly obese patients after sleeve gastrectomy

2013 ◽  
Vol 9 (4) ◽  
pp. 498-502 ◽  
Author(s):  
Francesca Abbatini ◽  
Danila Capoccia ◽  
Giovanni Casella ◽  
Emanuele Soricelli ◽  
Frida Leonetti ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Sleeve Gastrectomy ◽  
Morbidly Obese ◽  
Obese Patients

Laparoscopic sleeve gastrectomy: Effect on long-term remission for morbidly obese patients with type 2 diabetes at 5-year follow up

Surgery ◽  
2017 ◽  
Vol 162 (4) ◽  
pp. 857-862 ◽  
Author(s):  
Marius Nedelcu ◽  
Marcelo Loureiro ◽  
Mehdi Skalli ◽  
Florence Galtier ◽  
Audrey Jaussent ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Sleeve Gastrectomy ◽  
Laparoscopic Sleeve Gastrectomy ◽  
Morbidly Obese ◽  
Obese Patients

scholarly journals Gastric bypass significantly improves quality of life in morbidly obese patients with type 2 diabetes

2016 ◽  
Vol 30 (7) ◽  
pp. 2857-2864 ◽  
Author(s):  
Philip Omotosho ◽  
Alessandro Mor ◽  
Prapimporn Chattranukulchai Shantavasinkul ◽  
Leonor Corsino ◽  
Alfonso Torquati
Keyword(s):  
Quality Of Life ◽  
Type 2 Diabetes ◽  
Gastric Bypass ◽  
Morbidly Obese ◽  
Obese Patients

scholarly journals Early Postoperative Outcomes and Medication Cost Savings after Laparoscopic Sleeve Gastrectomy in Morbidly Obese Patients with Type 2 Diabetes

2011 ◽  
Vol 2011 ◽  
pp. 1-5 ◽  
Author(s):  
Bethany J. Slater ◽  
Nina Bellatorre ◽  
Dan Eisenberg
Keyword(s):  
Type 2 Diabetes ◽  
Sleeve Gastrectomy ◽  
Laparoscopic Sleeve Gastrectomy ◽  
Cost Savings ◽  
Diabetes Remission ◽  
Medication Cost ◽  
Morbidly Obese ◽  
Model Assessment ◽  
Obese Patients

Background. We investigated the effect of laparoscopic sleeve gastrectomy (LSG) on morbidly obese diabetics and examined the short-term impact of LSG on diabetic medication cost.Methods. A prospective database of consecutive bariatric patients was reviewed. Morbidly obese patients with type 2 diabetes who underwent LSG were included in the study. Age, gender, body mass index (BMI), diabetic medication use, glucose, insulin, and HbA1c levels were documented preoperatively, and at 2 weeks, 2 months, 6 months, and 12 months postoperatively. Insulin resistance was estimated using the homeostatic model assessment (HOMA). Use and cost of diabetic medications were followed.Results. Of 178 patients, 22 were diabetics who underwent LSG. Diabetes remission was observed in 62% of patients within 2 months and in 75% of patients within 12 months. HOMA-IR improved after only two weeks following surgery (16.5 versus 6.6, ). Average number of diabetic medications decreased from 2.2 to <1, within 2 weeks after surgery; corresponding to a diabetes medication cost savings of 80%, 91%, 99%, and 99.7% after 2 weeks, 2 months, 6 months, and 12 months, respectively.Conclusion. Morbidly obese patients with diabetes who undergo LSG have high rates of diabetes remission early after surgery. This translates to a significant medication cost savings.

Sign in / Sign up

Export Citation Format

Share Document